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ABSTRACT
Background: Candida species have long been recognised as aetiological agents of opportu-
nistic infections of the oral mucosa, and more recently, as players of polymicrobial interac-
tions driving caries, periodontitis and oral carcinogenesis.
Methods: We studied the clonal structure of Candida spp. at oral niche resolution in patients 
(n = 20) with a range of oral health profiles over 22 months. Colonies from oral micro- 
environments were examined with multilocus sequencing typing.
Results: Candida spp. identified were C. albicans, C. glabrata and C. dubliniensis. Increased 
propensity for micro-variations giving rise to multiple diploid strain types (DST), as a result of 
loss of heterozygosity, was observed among C. albicans clade 1 isolates compared to other 
clades. Micro-variations among isolates were also observed in C. dubliniensis contra to 
expectations of stable population structures for this species. Multiple sequence types were 
retrieved from patients without clinical evidence of oral candidosis, while single sequence 
types were isolated from oral candidosis patients.
Conclusion: This is the first study to describe the clonal population structure, persistence and 
stability of Candida spp. at oral niche level. Future research investigating links between 
Candida spp. clonality and oral disease should recognise the propensity to micro-variations 
amongst oral niches in C. albicans and C. dubliniensis identified here.
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Introduction
The oral cavity comprises a diverse set of niches 
inhabited by diverse microbial colonisers of prokar-
yotic (bacteria) and eukaryotic (yeasts and filamen-
tous fungi) microorganisms. Distinct micro- 
environments harbour microbial communities of 
planktonic cells in salivary fluids, and of adherent 
and filamentous multi-species biofilms growing on 
the surface of teeth, the tongue and mucosal mem-
branes [1,2]. Multi-species and cross-kingdom co- 
aggregations among complex biofilms contribute to 
ecological homeostasis during host health, and are 
important factors in the transition to dysbiosis and 
disease progression [3]. As such most oral diseases 
are caused by dysbiotic shifts within the microbial 
communities where ‘pathobionts’ such as Candida 
spp. thrive quantitatively and functionally.
Candida spp. are the main aetiological agent of oro-
pharyngeal mycoses that present in patients with predis-
posing systemic factors such as immune deficiencies as 
well as local factors such as denture wearing, smoking 
and salivary hypofunction. In addition, Candida spp. 
contribute to the cariogenic process acting synergistically 
with Streptococcus mutans to increase adherence proper-
ties which promotes community expansion and causes 
tissue damage [4,5]. Candida spp. are also prevalent in the 
periodontal environment – a synergistic role similar to 
that occurring within cariogenic biofilms is hypothesised 
although no mediating mechanism has yet been con-
firmed [6,7].
Molecular epidemiology and study of the popula-
tion structure of Candida spp. in the oral cavity 
develops our understanding of their role in oral 
health and disease. Multi-Locus Sequence Typing 
(MLST) is largely accepted as the standardised mea-
sure of population structure for Candida spp. [8–13]. 
Notwithstanding that 18S ribosomal DNA subunit 
and whole-genome sequencing are also usefully 
applied [14], MLST has been instrumental in defining 
the accepted model of C. albicans population struc-
ture as one of predominant clonality with rare recom-
bination events as a result of cryptic mating strategies 
generating new highly differential strain types, and 
more often, incremental mutation events such as 
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point mutations and loss of heterozygosity (LOH) 
providing low level, within population, genetic diver-
sity [15–21]. Stability and plasticity among 
C. albicans populations using serial isolate MLST 
studies conducted over several months and years 
revealed micro-variations associated with the emer-
gence of resistant phenotypes [22,23]. A more 
marked clonality among molecular types with highly 
stable population structure has been observed among 
commonly isolated, yet less pathogenic, non-albicans 
Candida spp. such as C. dubliniensis [9], C. glabrata 
[24], and C. tropicalis [25], although micro-variation 
amongst sequential clonal isolates has been reported 
in these Candida spp [26–28].
Enrichment and stability of species and strain types 
among colonising populations of Candida spp. causa-
tive of specific infection types have been highlighted by 
MLST studies [6,24,29]. C. albicans is the major cause of 
oral fungal infections and readily forms mixed species 
biofilms with partner Candida spp. of more clonal 
population structures, such as with C. glabrata in den-
ture stomatitis lesions [30], or with C. dubliniensis in 
HIV patients [31]. Enrichment of C. albicans DSTs has 
been reported among epidemiological groups, for 
example, of clade 1 DSTs among isolates from period-
ontitis patients [6]. However, such correlations are 
often not always reproducible [32]. C. albicans DSTs 
are frequently varied within population groups; for 
example, among isolates from childhood caries cases 
[33]. Moreover, C. albicans micro-variations, which 
may arise during the course of serial sampling studies 
[23,29], give rise to new DSTs which contribute an 
inherent dynamic temporal instability to the phyloge-
netic topologies that define strain type clades for 
Candida species.
We set out to assess the persistence and stability 
of Candida spp. and MLST strain types amongst oral 
micro-environments of a cohort of 20 dental 
patients comprising patients suffering from oral 
mucosal candidosis and participants with no history 
of oral candidosis. Sampling strategy was designed 
to allow detection of population strain type variation 
and evolution of antifungal resistance within the 
same patient by sequencing several colonies from 
multiple oral sites for each patient and repeating 
sampling multiple times where possible within 
a 2-year period.
To the best of our knowledge, this is the first 
longitudinal study of multiple Candida spp. 
through MLST at the oral niche level.
Materials and methods
Patient recruitment and sampling
Ethical consent: Ethical approval for involvement of 
human participants in this study was granted by 
North of Scotland Research Ethics Service (REC 
reference number 12/NS/0006). Written informed 
consent was obtained from all subjects according to 
the World Health Organisation guidelines for Good 
Research Practice.
Patient recruitment. Participants were recruited 
from patients attending routine clinics at the 
University of Aberdeen Dental Hospital. Oral candido-
sis and periodontitis cases were diagnosed using 
accepted clinical criteria [34,35]. Patient assessment 
included a full history, neck and oral mucosae examina-
tion, tooth charting, periodontal health assessment, 
measurement of plaque index and whole salivary flow 
rate. The sample cohort consisted of 20 dental patients 
with a range of oral and general health statuses includ-
ing 8 participants without oral mucosal candidosis and 
12 patients with oral candidosis and a range of predis-
posing factors. Clinical characteristics of the patient 
cohort are reported in Supplemental Table S1.
Sampling strategy: Patients samples were collected 
from the following oral micro-environments: plaque 
and calculus from subgingival and supragingival sites, 
unstimulated whole saliva samples, tongue dorsum 
scrapings, swabs from buccal and palatal mucosa 
(both healthy and inflamed sites in oral candidosis 
patients). Swabs were stored in Amies medium for 
transportation of aerobes and anaerobes (MWE, 
Wiltshire, England). Plaque, calculus, scrapings and 
swabs were suspended in phosphate-buffered saline 
(PBS). Samples were transported and stored at 4°C 
prior to downstream experiments within the same 
working day. Serial sampling from three patients was 
conducted over 1–17 month periods. As shown in 
Figure 1 the sampling effort from different oral sites 
amongst the cohort of 20 patients was slightly uneven: 
palate 65%, supragingival 65%, subgingival 85%, saliva 
100%, dorsum of tongue dorsum 95%, and buccal 
mucosa 75%. Frequency of the niche sampling relative 
to total sampling events was as follows: palate 60%, 
supragingival 60%, subgingival 83%, saliva 100%, dor-
sum of tongue 93%, and buccal mucosa 77%.
Species identification of Candida spp. isolates
Patient samples were plated and purified on 
Sabouraud dextrose (Sabdex) agar plates containing 
1% mycological peptone (w/v), 4% (w/v) glucose and 
2% (w/v) agar with chloramphenicol (50 μg/mL) and 
gentamycin (20 μg/mL) and incubated at 30°C, for 
48 h and checked at 24 h for growth. Enrichment of 
lower abundance sample types (plaque and calculus) 
were inoculated to YPD broth cultures (1% yeast 
extract, 2% bacto-peptone and 1% glucose) with 
chloramphenicol (50 μg/mL) and gentamycin 
(20 μg/mL) and incubated at 30°C, for 48 hrs and 
checked at 24 h for growth. Aliquots of YPD enrich-
ment cultures were plated and purified on Sabdex 
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agar, incubated at 30°C for 48 h and checked at 24 h 
for growth. Six colonies were selected from separate 
areas of culture positive Sabdex plates and grown in 
YPD at 30°C overnight for preparation of glycerol 
stocks (stored at −80°C) and genomic DNA. 
CHROMagar Candida chromogenic growth media 
[36] and ITS diagnostic PCR product sequencing 
[37] were used as previously described for species 
identification prior to sequencing isolates for MLST.
Antifungal susceptibility testing
Minimum inhibitory concentrations were determined 
by broth micro-dilution testing following the 
EUCAST and CLSI guidelines [38,39]. The drug con-
centrations ranged from 0.032 mg/ml to 16 mg/ml for 
caspofungin and amphotericin B, and 0.13 mg/ml to 
64 mg/ml for fluconazole and voriconazole. Each 
drug was serially diluted with sterile water to 50 μl 
in flat bottomed 96 well plates. Cultures were grown 
in NGY medium (0.1% (w/v) neopeptone, 0.4% (w/v) 
glucose, and 0.1% (w/v) yeast extract) for 12 h at 30° 
C until exponential phase, and 20 μl were transferred 
to 11 ml RPMI inoculation medium (2 x RPMI-1640, 
2% (w/v) glucose, buffered to pH 7.0 with MOPS). 
Aliquots of 50 μL inocula in RPMI were added to 
drug plates (total volume 100 μL), incubated for 24 h 
at 37°C and analysed using a VERSAmax microplate 
reader at 405 nm. Three colonies of each sequence 
type from each patient, at each sample time point 
were assayed in triplicate technical replicates and 
the experiment repeated for confirmation.
Genomic DNA extraction
Pelleted overnight liquid YPD cultures were trans-
ferred to 2 mL Eppendorf tubes and vortexted for 
5 min in the presence of 0.3 g of acid washed glass 
beads, 200 μL extraction buffer (2% Triton X-100, 
1% SDS, 100 mM NaCl, 10 mM Tris pH 8.0, 1 mM 
EDTA), 200 μL phenol: chloroform alcohol (1:1). 
TE buffer (200 μL, Tris EDTA pH 7.5) was added 
and the tubes inverted. Phase separation by centri-
fugation for 5 min at 14,000 g was followed by 
transfer of the aqueous layer to 1 mL of 100% 
EtOH in 2 mL tubes and centrifugation for 2 min 
at 14,000 g to obtain precipitated DNA. Pelleted 
DNA was resuspended in 400 μL TE plus 10 μL 
RNase A (10 mg ml-1) and incubated for 20 min at 
37°C, subsequent precipitation in 20 μL 3 M NaOAc 
and 1 mL 100% EtOH with centrifugation at 
14,000 g for 10 min was followed by resuspension 
in 200 μL sterile H2O, as previously described [40].
PCR and sequencing
PCR reactions were performed in 20 uL volumes in 96 
well microtitre plates using high-fidelity DNA poly-
merase (Finnzymes Phusion F-530 L) according to 
the manufacturer’s instructions with first cycle dena-
turation for 2 min at 94°C, followed by 25 cycles of 
denaturation at 94°C for 1 min, annealing at 52°C for 
1 min, elongation at 72°C for 1 min, and a final exten-
sion step of 10 min at 72°C and as previously described 
[12]. The PCR product (5 μL) was purified using Mag- 
Bind E-Z Pure solution and eluted in 20 μL of sterile H2 
O according to the manufacturer’s instruction.
Bi-directional sequencing reactions were per-
formed as previously described [14,41,42] in 5 μL 
volumes comprising 1 μL of purified PCR product, 
2 μL diluted primer (1:15 dilution, with sterile H2O), 
2 μL BigDye cocktail (for 200 samples 50 μL Big Dye, 
175 μL 5 x Buffer, 175 μL sterile H2O) in 96 well 
microtitre plates. The reactions proceeded for 25 
Table 1. C. albicans MLST DSTs for typed colonies. Diploid sequence types (DSTs) for C. albicans isolates showing the sequence 
type numbers for each sequenced region and clade membership and the number of colonies sequenced. DSTs have been 
submitted to the central MLST database; newly identified DSTs are highlighted green.
Patient N AAT1a ACC1a ADP1 MPIb SYA VPS13 ZWF1b DST Clade
P2 24 5 32 21 34 7 55 5 732 3
P3 22 2 3 5 2 2 20 5 237 1
P4 18 13 2 4 4 4 4 255 2422 2
P5 6 2 77 5 31 2 3 5 2118 1
P9 120 13 10 15 6 7 55 12 2119 3
P10(a) 16 2 3 5 2 2 21 5 110 1
P10(b) 1 2 5 5 2 2 21 5 37 1
P11 18 4 17 21 19 27 32 22 88 12
P12 24 4 7 4 4 4 26 4 497 2
P13(a) 1 11 5 5 4 2 20 5 2423 1
P13(b) 5 31 5 5 2 2 21 5 375 1
P13(c) 6 120 5 5 4 2 20 5 2126 1
P16 6 4 2 4 4 34 4 204 2120 2
P18(a) 27 31 5 5 2 2 21 5 375 1
P18(b) 2 31 3 5 2 2 21 5 2122 1
P18(c) 1 31 5 5 2 2 24 12 2131 1
P18(d) 6 31 5 5 2 2 21 12 2424 1
P20 66 71 13 6 1 7 218 15 2123 8
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cycles of 96°C for 10 sec, 52°C for 5 sec, 60°C for 
2 min and held at 10°C. The products were purified 
by addition of 10 μL sterile H2O to prevent dye blobs, 
and 50 μL precipitation solution (48 μL 100% EtOH, 
2 μL 3 M NaOAc pH 4.6). Incubation for 45 min at 
RT was followed by centrifugation at 4°C for 1 h at 
2,254 g, washing in 150 μL 70% EtOH with 10 min 
centrifugation 2,254 g at 4°C, drying for 2 min at 80° 
C and storage at −20°C until dispatch for sequencing. 
Sequencing was performed on ABI 3730 instruments 
by the Zoology Department of the University of 
Oxford (Oxford, UK).
Phylogenetic analysis
DNA sequence results were analysed and SNPs deter-
mined using Lasergene SeqMan Pro software by 
DNASTAR (https://www.dnastar.com/). Strain types 
Figure 1. Candida spp. colonies typed from oral niches.
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were further confirmed by subsequent re-sequencing 
using genomic DNA freshly prepared from cultures 
grown from stored −80°C glycerol strain stocks. DSTs 
were submitted to the C. albicans (http://calbicans. 
mlst.net/) and C. glabrata (http://cglabrata.mlst.net/) 
MLST central curation databases. Multiple sequence 
alignment and tree building with the Unweighted 
Pair Group Method with the Arithmetic Mean 
(UPGMA) method was performed using Clustal 
Omega [43]. Splits phylogenies were prepared from 
diploid sequence type (DST) profiles of C. glabrata 
and C. albicans in SplitsTree4 v4.13.1 [44]. eBurst 
analysis was performed with eBURSTv3 [45]. Beast 
was used with Beauti, Tree Annotator and 
LogRecombiner to create ML trees including 
C. dubliniensis sequences and visualised using 
FigTree v1.4.0 [46–48]. PHASE [49], was used to 
infer phased haplotypes for micro-variants, and vari-
able base position frequencies for micro-variant 
populations were visualised with WebLogo 3 [42].
Results
Candida spp. and clonal distribution within the 
study cohort
The study cohort consisted of 20 dental patients 
with a range of oral and general health statuses 
including 8 control subjects without clinically diag-
nosed candidosis (P4, P6, P7, P8, P13, P14, P15 and 
P18) and 12 patients with oral mucosal candidosis 
Table S1). MLST sequence analysis was conducted 
for 369 C. albicans isolates, 113 C. glabrata isolates 
and 68 C. dubliniensis isolates cultured from clinical 
samples collected from 6 oral niches. Six out of 
eight patients without clinical oral candidosis were 
positive for Candida. spp., consistently with carriage 
levels cited among healthy individuals [50]. Of these 
six patients, three patients yielded C. albicans, 
1 C. glabrata (P6, a partial denture-wearer) and 
2 C. dubliniensis (P15 and P8 non-denture wearers 
with periodontitis) (Figure 1, Table S1). Of four 
non-denture-wearing participants without oral 
mucosal candidosis, only one proved negative for 
Candida spp. (P14) (Figure 1, Table S1).
Ten out of 12 patients diagnosed with oral muco-
sal candidosis yielded Candida spp. (P10, P11, P16, 
P1, P2, P3, P5, P9, P12, P20). All oral candidosis 
patients yielded C. albicans except for P1 who yielded 
C. glabrata alone. An HIV-positive patient with 
severe periodontitis and partial dentures yielded 
C. albicans in co-occurrence with C. dubliniensis 
(P10) while another patient yielded C. albicans with 
C. glabrata (P5) (Figure 1, Table S1).
The majority of sequence types in this study were 
retrieved from two patients presenting without oral can-
didosis clinically: P18 (partial denture-wearer with severe 
periodontitis) and P13 (non-denture wearer with type 1 
diabetes). Patients yielding a single DST from clade 
1 C. albicans presented with clinical oral candidosis with-
out periodontitis. Both patients yielding C. albicans with 
C. glabrata (P5) and with C. dubliniensis (P10) yielded 
clade 1 C. albicans isolates. C. albicans isolates not in clade 
1 were retrieved exclusively from patients presenting with 
clinical oral candidosis with the exception of one patient 
(P4; smoker, denture-wearer, severe periodontitis) 
(Figure 1, Table S1).
Diagram showing number of colonies at the oral niche 
level from the study cohort. Patient unique identifiers as 
well as serial sampling events per patient are enumerated 
vertically. The number of colonies obtained for each of 
the 6 oral niches is indicated in each row with colour- 
coding for each Candida species as follows: green 
cells = C. glabrata isolates; light blue cells = C. albicans 
isolates; pink cells = C. dubliniensis isolates. Blank 
cells = sites not sampled; n.d. = no isolates detected. 
Instances where sub-/supra-gingival sites were sampled 
more than once are indicated in the same cell and sepa-
rated by a semi-colon. Isolates retrieved from calculus are 
indicated in bold. Where more than one diploid sequence 
type (DST) was identified, ‘a, b, c’ is marked in parenth-
esis along with the number of colonies for each DST that 
were obtained. The total number of DSTs identified is 
given in parenthesis.
Candida spp. at oral niches
Of 20 patients sampled, 80% were positive for 
Candida spp. In respect of niches sampled from 
Candida spp. positive participants, saliva and tongue 
surface samples yielded isolates most frequently (83% 
and 81% positive), while supra-gingival and sub- 
gingival samples yielded least often (56% and 38% 
positive), and buccal mucosal and hard palate swabs 
were positive for Candida spp. in 67% and 68%, 
respectively. Higher retrieval of Candida isolates 
from tongue and saliva should be viewed in the con-
text of a slightly higher sampling frequency from 
tongue and saliva as compared to other sites (Figure 
1). Sub-gingival samples yielded Candida isolates 
least frequently despite a higher sampling frequency 
for this site as compared to palate, buccal mucosa and 
supra-gingival plaque.
C. albicans was the most abundantly isolated (369 
isolates) accounting for 67% of typed colonies. 
C. albicans was also the most frequently present 
Candida spp. across the niches sampled, in respect 
of niches sampled among all participants (33%) as 
well as across Candida spp. positive participants 
(42%); with C. glabrata (12% and 15%) and 
C. dubliniensis (8% and 9%) second and third, respec-
tively (Figure 2 A-B). Non-albicans Candida spp. 
were identified in six participants; three yielded 
C. glabrata (including one as co-present with 
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C. albicans) and three participants yielded 
C. dubliniensis (including one as co-present with 
C. albicans). Across all patients, each of these three 
species were found at least once at each of the niches 
sampled, with the exception of the hard palate which 
did not yield C. dubliniensis.
The proportion of Candida spp. positive niches 
from patients positive for each specific Candida 
spp., was highest for C. glabrata (77%), owing largely 
to 100% isolation from the tongue surface and buccal 
mucosa sites (Figure 2C). C. dubliniensis isolation 
was the most consistently retrieved species at gingival 
sites (67%), but less consistent over all niches (52%) 
than C. albicans (63%) (Figure 2C). Both C. glabrata 
and C. dubliniensis were more consistently retrieved 
across all niches among patients also yielding 
C. albicans.
The number of colonies and frequency of isolation 
of Candida species sampled from 6 oral niches of 20 
patients is given. Sites above and below the gingival 
margin are Sup.G and Sub.G, respectively, other sites 
are whole saliva, the dorsum of the tongue, the hard 
palate and the buccal mucosa.
Population structure of Candida spp.
C. albicans population structure at oral niche level. Of 
the 17 C. albicans DSTs we identified, only 7 had been 
reported previously (Table 1). A new sequence type for 
the ZWF1a region was identified from a clade 2 P4 
isolate and designated ZWF1a ST 255 through the cen-
tral C. albicans MLST curation service. ZWF1a ST 255 
was distinguished from the closest matching sequence 
ST 4 by the 47th base of the sequence being heterozy-
gous R rather than homozygous G.
Isolates from clade 1 were the most frequent 
among the isolates. This was also the only clade to 
contain multiple isolates from individual participants. 
DSTs from 5 of the 20 patients comprised 10 clade 1 
DSTs, 4 of which had been previously reported; DST 
88 and DST 497 (P10), DST 273 (P3), and the only 
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Figure 2. Summary of Candida spp. presence at oral niches.
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P18) – DST 375. Multiple C. albicans DSTs were 
identified from sample material from each of three 
patients: P10 (2 DSTs), P13 (3 DSTs) and P18 (4 
DSTs) – all clade 1 isolates. From P3 and P5 two 
further clade 1 DSTs were retrieved (DST 237 and 
DST 2118, respectively) (Table 1).
The average pairwise distance of clade 1 isolates (0.39 
between all, 0.4 between isolates from separate patients) 
was lower than that of other clades for which multiple 
DSTs were identified, clade 2 (0.52) and clade 3 (0.71). 
The clade 2 (3 DSTs) and clade 3 isolates (2 DSTs) each 
included a single previously identified DST (DST 497 
and DST 732, respectively), the remaining previously 
identified DST (DST 88 from P11) belonged within 
clade 12. The final remaining DST 2123, a clade 8 isolate, 
was identified in a patient presenting with widespread 
and severe erythematous candidosis secondary to long- 
term use of broad-spectrum antibiotics (P20) and had 
not been previously reported. P13 and P18 isolates 
comprised 35% of all DSTs and 60% of clade 1 DSTs, 3 
sequence types for each of AAT1a and VPS13, and 2 for 
ACC1a. The MP1b and ZWf1a regions were identified 
for these DSTs. Determination of the haplotype phase 
for these micro-variant isolates revealed that micro- 
variant DSTs consisted of variant types for ACC1a, 
MP1b and ZWf1a that were distinguishable from DST 
375 in being homozygous at a series of consecutive 
SNPs – a pattern of LOH (Figure 3 and Figure S1).
Phylogenetic analysis of AAT1a and VPS13 indepen-
dently including also their computationally phased var-
iant counterpart sequences, demonstrated that DST 375 
commanded the least average distance from each of the 
phased micro-variant sequences. Together with 
eBURST analysis of DST profiles these data indicated 
that clade 1 isolates identified within this study 
comprised micro-evolutionary changes across the 
sequenced regions as a result of LOH events which 
also occasionally involved additional point mutations 
(AAT1a and VPS13) stemming from the progenitor 
DST 375 (Figure 3 and Figure S1).
C. glabrata and C. dubliniensis population struc-
ture at oral niches. C. dubliniensis sequence types 
were also distinct between participants, two distinct 
sequence types were identified from both P10 and P8, 
and a single sequence type identified from P15 
(Figure 1). Currently, C. dubliniensis is without 
a centrally curated MLST database. Thus, no 
sequence type numbering system is applicable. 
Previous studies have implemented varied primer 
combinations usually including several regions 
included in the closely related C. albicans MLST 
scheme and the addition of RPN2 to reinforce dis-
criminatory power [9,40,51]. The six core MLST 
regions shared directly with the C. albicans MLST 
scheme (ACC1a, ADP1, MP1b, SYA, VPS13 and at 
the ZWF1 region) identified 26 SNPs that distin-
guished 5 sequence types. Nine SNPs separated two 
P8 sequence types, and 5 SNPs separated two P10 
sequence types – interestingly in both cases, only one 
SNP was a heterozygous/homozygous mutation. 
Phylogenetic analysis confirmed within-patient 
monophyly for micro-variant C. dubliniensis isolates 
from P8 and P10 (Figure 4).
Each of the three C. glabrata MLST sequence types 
(STs) identified in this study have been reported in 
previous studies, and are from distinct clonal clusters 
(CCs). A single ST was identified for each of three 
patients, P1 (ST 22, CC 15), P5 (ST 24, CC 52), P6 
(ST 77, CC 77). C. glabrata (ST24, CC52) and 
C. albicans (DST 2118, clade 1) isolates were retrieved 
Figure 3. Population structure of C. albicans isolates. A) Phylogenetic network of C. albicans DSTs. Branches are coloured by 
clade as follows: 2, yellow; 12, green; 8, purple; 3, blue; 1, red; branches are grey where splits are shared. B) Cladogram (left) of 
P18 AAT1a microvariant sequences including the unphased ST (red) and both phased deconvolved sequences (blue) and 
nucleotide motif logos (right) for the unphased ST nucleotide variants (top) and phased haplotypes (bottom). C) eBURST analysis 
of C. albicans DSTs identified. The eBURST colouring convention for nodes is: founder, lime green; sub-founder, olive green; and 
for connecting line colours it is: high-level edges, gold; triple locus variant, red; double locus variant, green; branches are black 
and were without recourse to tiebreak rules.
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from P5. C. glabrata STs remained clonal for all three 
patients with no evidence of micro-variation amongst 
niches or sample time points (Table 2 and Figure 4).
Antimicrobial susceptibility
Antifungal resistance profiles for these isolates were 
generally unremarkable, with no differences identi-
fied between isolates of the same species from the 
same patient that would otherwise indicate the devel-
opment of resistance during the course of the study 
(data not shown). Minimum inhibitory concentra-
tions were calculated as MIC 90 values for caspofun-
gin, AmBisome and fluconazole on a per patient for 
C. albicans, C. glabrata and C. dubliniensis basis 
rather than for each sequence type. No changes in 
MIC resulted in the susceptibility exceeding the 
reported break-points for specific Candida species 
and specific antifungal agents (data not shown).
Discussion
This study employed a high-resolution sampling strat-
egy to examine multiple colonies from multiple oral 
niches sampled from a clinically diverse cohort at multi-
ple time points over 22 months. Specifically, this 
approach has the potential to identify micro-variants 
directly associated with specific phenotypes. Although 
micro-evolutionary changes had taken place among 
isolates from the same patient, these did not coincide 
with any phenotypic advantage in terms of antifungal 
resistance contra to findings of a study of 43 isolates of 
C. albicans from 11 HIV patients with oro-pharyngeal 
candidosis [52].
Our study identified C. albicans as the predomi-
nant Candida spp. present with clade 1 being the 
most represented. Enrichment for C. albicans MLST 
clade 1 isolates with untreated periodontitis was pre-
viously reported [9]. Indeed, clade 1 isolates have 
emerged as the most commonly encountered clade 
among MLST sequence types generally [53,54].
There were a larger number of oral micro-niches 
colonised by and a larger number of strain types 
observed for C. dubliniensis isolates when present 
along with C. albicans. Equally, C. glabrata was 
more consistently retrieved across all niches among 
patients also yielding C. albicans. This suggests coop-
eration between these species in forming biofilm, 
rather than competitive colonisation, and potentially 
in generating a greater diversity of oral niches com-
pared with mono-species colonisation. The increased 
prevalence of C. albicans and C. glabrata in denture 
stomatitis has been observed in several previous 
Figure 4. Population structure of C. dubliniensis and C. glabrata isolates. A) Phylogenetic tree of C. albicans and C. dubliniensis 
isolates identified including also representative strain types of the major C. albicans clades. The tree is produced from MLST 
sequences using the maximum likelihood method and is rooted at the black node, branches are gradient coloured bootstrap 
probabilities (red-high, blue-low), and nodes are sized by bootstrap support and coloured by branch length (red-short, blue- 
long). B) Neighbour joining phylogeny of the phylogenetic tree of C. glabrata isolates identified (grey bold type) including also 
all isolates present in the MLST database at the time of production (small black and coloured type). The tree is produced from 
MLST sequences using the neighbour joining method. STs representative of major groups are coloured: Group 1, pink; Group 2, 
blue; Group 3a, red; Group 3b, blue-grey; Group 5, green).
Table 2. C. glabrata MLST STs for typed colonies. Sequence types (STs) determined by MLST for C. glabrata isolates showing the 
sequence type numbers for each sequenced region and clade membership and the number of colonies sequenced. STs have 
been submitted to the central MLST database.
Patient N FKS LEU2 NMT1 TRP1 UGP1 URA3 Sequence type Clonal cluster
P1 18 7 5 6 12 1 8 22 15
P5 22 9 9 10 4 3 2 24 52
P6 73 10 14 12 11 3 2 77 77
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studies [30,55–57] and their presence as dual species 
biofilm was highlighted [30]. The prevalence of 
C. dubliniensis and its association with HIV [31,58] 
and periodontitis has also been identified in several 
previous studies [58–60], and its co-occurrence with 
C. albicans was also highlighted [59]. Other Candida 
spp. which are often reported at higher prevalence 
than C. dubliniensis [7,55], and among denture sto-
matitis patients, e.g. C. krusei and C. parapsilosis 
[56,61], or in oral samples in general, e.g. 
C. tropicalis [61,62], were not observed in this cohort.
We showed that micro-variations in C. albicans, as 
a result of LOH events and occasional point muta-
tions, were responsible for the presence of multiple 
DSTs within individual patients and oral niches. The 
reduced pairwise phylogenetic distance and increased 
propensity for micro-variation observed among 
C. albicans clade 1 isolates was consistent with pro-
positions of an increased ability to evolve and 
reduced evolutionary constraint for clade 1 isolates 
compared to other clades. Future studies should con-
sider the potential role of recombination events 
through the para-sexual cycle in the evolutionary 
ability of clade 1 in addition to LOH events, in light 
of evidence demonstrating the importance of gene 
flow in the diversification of C. albicans clades [63]. 
Genetic diversification through micro-variation has 
been associated with exposure to adverse environ-
mental conditions [64]. On the other hand, the pos-
sibility that varying environmental conditions in 
healthy and infective states may themselves favour 
recurrent colonization by different clones should be 
considered.
We observed marked clonality and stability among 
C. glabrata isolates in keeping with previous evidence 
[24,65,66], notwithstanding recent data suggesting 
the potential phenotypic importance of genetic varia-
tions within infecting clonal populations [67]. On the 
other hand, we observed micro-variation among iso-
lates of C. dubliniensis from individual patients con-
tra to expectations of highly clonal population 
structures for this species [9,31,68].
In this study cohort, we did not find evidence of co- 
colonisation in the same patient by more than one line-
age of any of the three species. Co-infection by indepen-
dent lineages of C. parapsilosis was recently reported in 
a patient with post-surgical systemic infection [69].
We recognise the sampling unevenness amongst this 
patient cohort. However, detection of multiple sequence 
types of C. albicans and C. dubliniensis in patients who 
were sampled on a single occasion, and at the same time 
detection of a single sequence type in patients who were 
sampled at different time points, suggests that detection 
of multiple sequence types is not dependent on the 
number of serial sampling events in the same patient.
C. albicans isolates not in clade 1 were nearly exclu-
sively retrieved from oral candidosis patients. Overall, 
we detected higher clonal diversity in patients present-
ing without clinical evidence of oral mucosal candidosis 
but with risk factors for oral candidosis. On the other 
hand, patients yielding a single diploid strain type from 
clade 1 C. albicans presented with clinical oral candido-
sis. This interesting observation is in keeping with the 
reduced microbial diversity seen in association with oral 
inflammation [70]. However, associations between 
infective states and clonal variability levels cannot be 
derived from this study. Clearly, a much larger cohort 
would be required to implement statistical assertions as 
to associations of Candida spp. and/or strain types with 
particular clinical traits.
Computational deconvolution of the haplotypic 
phase among populations of micro-variants was used 
here with MLST datasets to implicate founder popula-
tion genetic types and assist in identifying progenitor 
strains types. These data highlight the potential for 
high-resolution sampling strategies combined with 
novel analytical approaches to make inferences when 
sampling longitudinally from a clinically diverse cohort.
Improved ability to make more in-depth analyses of 
Candida molecular epidemiology can be attained using 
empirically-derived phased sequence data from long- 
read, high-throughput MLST strategies [71,72] and gen-
ome-wide yeast and fungal population studies [73–77]. 
While we did not find evidence of recombination 
between different clades, as recently disclosed for collec-
tions of C. glabrata and C. albicans derived from 
a variety of niches and geographical areas [63,78], future 
genome-wide studies of oral isolates will determine the 
true extent of genomic rearrangements and aneuploidy.
Future studies using a combination of metagenetic, 
population genomic and host genotype sequencing, 
with systematic sampling strategies and large-scale 
phenotypic analysis will improve our ability to under-
stand the co-evolution of oral pathogens such as 
Candida spp. in the context of poly-species biofilm in 
health and disease. Longitudinal studies of the popula-
tion structure of Candida spp., such as the current 
study, are few and continue to contribute meaningfully 
alongside emerging high-throughput datasets that also 
include strain type surveillance [79, 80].
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